---
schema_version: "secwatch.filing_event.v1"
accession: "0001022079-25-000172"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:02:43.861989+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics Q2 revenues $2.76B (+15.2%), beats; raises FY2025 adjusted EPS guidance to $9.63-$9.83

## Summary
- Q2 revenue $2.76B, up 15.2% YoY; organic revenue growth 5.2%.
- Reported diluted EPS $2.47 (+21.7%); adjusted diluted EPS $2.62 (+11.5%).
- Cash from operations $544M in Q2 (+51.5%); YTD $858M (+67.1%).
- Raises full-year 2025 net revenue guidance to $10.80B-$10.92B (from $10.70B-$10.85B).
- FY2025 adjusted diluted EPS guidance raised to $9.63-$9.83 from $9.55-$9.80.

## SEC filing metadata
- accession: 0001022079-25-000172
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000102207925000172/0001022079-25-000172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000102207925000172/dgx-20250722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001022079-25-000172
- JSON: https://secwatch.observer/filing/0001022079-25-000172.json
- Plain text: https://secwatch.observer/filing/0001022079-25-000172.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.